Harvard Bioscience Inc (NASDAQ: HBIO) on Friday, plunged -18.00% from the previous trading day, before settling in for the closing price of $0.63. Within the past 52 weeks, HBIO’s price has moved between $0.28 and $2.82.
A company in the Healthcare sector has dropped its sales by -18.10% annually for the last half of the decade. The company achieved an average annual earnings per share of -16.67%. With a float of $38.07 million, this company’s outstanding shares have now reached $44.53 million.
In an organization with 355 employees, it is important to assess its efficiency.
Harvard Bioscience Inc (HBIO) Insider and Institutional Ownership
Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Harvard Bioscience Inc is 14.50%, while institutional ownership is 44.21%.
Harvard Bioscience Inc (HBIO) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.02 earnings per share (EPS) for the period falling under the consensus outlook (set at 0.01) by -0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -16.67% per share during the next fiscal year.
Harvard Bioscience Inc (NASDAQ: HBIO) Trading Performance Indicators
Harvard Bioscience Inc (HBIO) is currently performing well based on its current performance indicators. A quick ratio of 0.41 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.26. Likewise, its price to free cash flow for the trailing twelve months is 5.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.30, a number that is poised to hit 0.01 in the next quarter and is forecasted to reach 0.12 in one year’s time.
Technical Analysis of Harvard Bioscience Inc (HBIO)
Let’s dig in a bit further. During the last 5-days, its volume was 67.81 million. That was better than the volume of 5.61 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 51.98%.
During the past 100 days, Harvard Bioscience Inc’s (HBIO) raw stochastic average was set at 25.00%, which indicates a significant increase from 25.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0597 in the past 14 days, which was higher than the 0.0414 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4541, while its 200-day Moving Average is $0.6227. However, in the short run, Harvard Bioscience Inc’s stock first resistance to watch stands at $0.5727. Second resistance stands at $0.6288. The third major resistance level sits at $0.6744. If the price goes on to break the first support level at $0.4710, it is likely to go to the next support level at $0.4254. The third support level lies at $0.3693 if the price breaches the second support level.
Harvard Bioscience Inc (NASDAQ: HBIO) Key Stats
Market capitalization of the company is 23.00 million based on 44,531K outstanding shares. Right now, sales total 94,140 K and income totals -12,410 K. The company made 20,450 K in profit during its latest quarter, and -2,280 K in sales during its previous quarter.
